NEW YORK (Reuters Health) – In postmenopausal women with osteoporosis, the selective estrogen-receptor modulator lasofoxifene cuts the risks of fractures, estrogen-receptor-positive breast cancer, coronary disease, and stroke, the…
NEW YORK (Reuters Health) – In patients with HIV and tuberculosis (TB) whose CD4 cell counts are below 500/mm3, mortality is increased if antiretroviral therapy is delayed until…
NEW YORK (Reuters Health) – During early resuscitation in severe sepsis, lactate clearance can indicate tissue oxygen delivery as effectively as central venous oxygen saturation, with considerably less…
NEW YORK (Reuters Health) – Beta blockade before computed tomographic coronary angiography (CTA) can improve image quality, but a substantial number of patients who require CTA have contraindications…
NEW YORK (Reuters Health) – Survival of extremely premature infants (less than 26 weeks’ gestation) can’t be predicted by appearance at birth and early response to resuscitation, according…
NEW YORK (Reuters Health) – An implantable cardioverter-defibrillator (ICD) should be considered when patients with long QT syndrome (LQTS) have syncope while on beta-blockers. That’s according to authors…
NEW YORK (Reuters Health) – Daclizumab added to ongoing interferon-beta treatment further decreases multiple sclerosis disease activity, according to a multicenter phase II trial reported online February 16…
Ian A Cook, MD, Director of Unipolar Depression Research, UCLA David Geffen School of Medicine, discusses new treatment options for depression, particularly deep brain stimulation and injectable treatment…
NEW YORK (Reuters Health) – Intra-partum nevirapine, given to prevent HIV transmission, contributes to HIV resistance mutations to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) – but a one-month postpartum course…
NEW YORK (Reuters Health) – Researchers cut short a clinical trial of the endothelin blocker avosentan in patients with diabetic nephropathy because it was linked with fluid overload…